Market By Drug Class, Distribution Channel, End-user, And Geography | Forecast 2019-2028
According to Triton, the market for immunosuppressant drugs in Latin America is expected to proliferate with a CAGR of 5.94% in the forecast period of 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries scrutinized in this market include:
•          Brazil
•          Mexico
•          Rest of Latin America
Brazil’s healthcare industry is going through major changes and experiencing new business dynamics. This has made it one of the most promising and attractive markets in the world. Besides, the nation’s pharmaceutical market has shown significant progress, owing to the increase in household income, and thus, the growth in healthcare expenditure. The growth in the pharma sector has thus increased the adoption of immunosuppressant drugs, which has propelled the studied market’s growth in Brazil.
Brazil has been a pioneer in the field of organ transplantation, making numerous advancements. At present, the nation stands second in the list of countries with the highest number of organ transplants. It is necessary to give immunosuppressants to transplant patients, and hence, an increase in the number of these procedures will increase the demand for immunosuppressant drugs. This factor is aiding the growth of the Brazilian immunosuppressant drugs over the forecasted period.
The pharmaceutical industry in Mexico is flourishing, and is the11th-largest pharma industry in the world. In the Latin American region, it is the 2nd-largest pharmaceutical market, after Brazil. This sector has been traditionally stable, marking huge profits; however, in recent years, it has undergone major changes, and is expanding even further. The rapid growth in this industry has positively influenced the demand for immunosuppressant drugs, thereby propelling the growth of the market over the forecasting years.
Astellas Pharma Inc manufactures, markets, imports, and exports pharmaceuticals and related products. It primarily manufactures prescription drugs, which fall under the therapeutic categories of immunology, urology, nephrology, oncology, ophthalmology, muscle diseases, infectious diseases, and neuroscience. Graceptor, FK506, and ASP0485 are the various immunosuppressant drugs produced by the company. Astellas has a notable presence in Latin America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1. LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1.  ORGAN TRANSPLANTATION LEADS MARKET BY END-USER
2.2.2.  PHARMACEUTICAL INDUSTRY SHOWING GROWTH TRENDS
2.2.3.  IMPACT OF COVID-19 ON TRANSPLANT RECIPIENTS
2.3. EVOLUTION & TRANSITION OF IMMUNOSUPPRESSANT DRUGS
2.4. PORTER’S FIVE FORCE ANALYSIS
2.4.1.  THREAT OF NEW ENTRANTS
2.4.2.  THREAT OF SUBSTITUTE
2.4.3.  BARGAINING POWER OF SUPPLIERS
2.4.4.  BARGAINING POWER OF BUYERS
2.4.5.  THREAT OF COMPETITIVE RIVALRY
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. MARKET DRIVERS
2.7.1.  DEMAND FROM ORGAN TRANSPLANTATION
2.7.2.  RISE IN THE NUMBER OF AUTOIMMUNE DISORDERS
2.8. MARKET RESTRAINTS
2.8.1.  SIDE-EFFECTS OF IMMUNOSUPPRESSANT DRUGS
2.9. MARKET OPPORTUNITIES
2.9.1.  DEMAND FROM EMERGING ECONOMIES
2.9.2.  EXPORTS OF DRUGS AND MEDICINE WORLDWIDE ON RISE
2.10. MARKET CHALLENGES
2.10.1. LACK OF AWARENESS ABOUT ORGAN DONATION
3. LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET OUTLOOK – BY DRUG CLASS
3.1. CORTICOSTEROIDS
3.2. MONOCLONAL ANTIBODIES
3.3. CALCINEURIN INHIBITORS
3.4. MTOR INHIBITORS
3.5. OTHERS
4. LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET OUTLOOK - BY DISTRIBUTION CHANNEL
4.1. HOSPITAL PHARMACIES
4.2. RETAIL PHARMACIES
4.3. ONLINE PHARMACIES
5. LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET OUTLOOK - BY END-USER
5.1. ORGAN TRANSPLANTATION
5.2. AUTOIMMUNE DISORDERS
5.3. OTHERS
6. LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET – REGIONAL OUTLOOK
6.1. BRAZIL
6.2. MEXICO
6.3. REST OF LATIN AMERICA
7. COMPETITIVE LANDSCAPE
7.1. ABBVIE INC
7.2. ALLERGAN (ACQUIRED BY ABBVIE INC)
7.3. ASTELLAS PHARMA INC
7.4. BRISTOL-MYERS SQUIBB COMPANY
7.5. CIPLA LTD
7.6. DR REDDYS LABORATORIES LTD
7.7. F HOFFMANN-LA ROCHE LTD
7.8. GLAXOSMITHKLINE PLC
7.9. INTAS PHARMACEUTICALS LTD (ACCORD HEALTHCARE)
7.10. JANSSEN PHARMACEUTICALS INC (JOHNSON & JOHNSON SERVICES INC)Â Â Â Â Â Â Â
7.11. MYLAN NV
7.12. NOVARTIS AG
7.13. PFIZER INC
7.14. SANOFI
7.15. VELOXIS PHARMACEUTICALS INC
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY
TABLE 1: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: SIDE-EFFECTS OF IMMUNOSUPPRESSANT DRUGS
TABLE 5: TOP 15 POSITIVE NET EXPORTS COUNTRIES AND NEGATIVE NET EXPORTS FOR DRUGS & MEDICINES COUNTRIES
TABLE 6: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY DRUG CLASS, 2019-2028 (IN $ MILLION)
TABLE 7: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (IN $ MILLION)
TABLE 8: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE 9: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1: EVOLUTION & TRANSITION OF IMMUNOSUPPRESSANT DRUGS
FIGURE 2: PORTER’S FIVE FORCE ANALYSIS
FIGURE 3: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $ MILLION)
FIGURE 4: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY MONOCLONAL ANTIBODIES, 2019-2028 (IN $ MILLION)
FIGURE 5: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY MTOR INHIBITORS, 2019-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY OTHERS, 2019-2028 (IN $ MILLION)
FIGURE 8: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY RETAIL PHARMACIES, 2019-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY ONLINE PHARMACIES, 2019-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY ORGAN TRANSPLANTATION, 2019-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY AUTOIMMUNE DISORDERS, 2019-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY OTHERS, 2019-2028 (IN $ MILLION)
FIGURE 14: LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 15: BRAZIL IMMUNOSUPPRESSANT DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 16: MEXICO IMMUNOSUPPRESSANT DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 17: REST OF LATIN AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, 2019-2028 (IN $ MILLION)